He has played just six first-class games after making his debut in a tour match against New Zealand just under two years ago.

BBC: Teen bowler Josh Hazlewood gets Australia call-up

Aventis, the only big drug firm claiming to have a new class of antibiotic that's likely to win approval soon, is still held up after a two-year regulatory delay.

FORBES: Magazine Article